Live stream preview
The potential of CDK4 inhibition in anti-melanoma therapy Karen Shepperd
Australasian Melanoma Conference 2018
•
16m
Up Next in Australasian Melanoma Conference 2018
-
Targeting pro-survival BCL-2 proteins...
-
Repurposing epigenetic drugs to prime...
-
Survivorship issues for patients with...